mesalamine has been researched along with Hyperoxaluria, Primary in 1 studies
Mesalamine: An anti-inflammatory agent, structurally related to the SALICYLATES, which is active in INFLAMMATORY BOWEL DISEASE. It is considered to be the active moiety of SULPHASALAZINE. (From Martindale, The Extra Pharmacopoeia, 30th ed)
mesalamine : A monohydroxybenzoic acid that is salicylic acid substituted by an amino group at the 5-position.
Hyperoxaluria, Primary: A genetic disorder characterized by excretion of large amounts of OXALATES in urine; NEPHROLITHIASIS; NEPHROCALCINOSIS; early onset of RENAL FAILURE; and often a generalized deposit of CALCIUM OXALATE. There are subtypes classified by the enzyme defects in glyoxylate metabolism.
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 1 (100.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Moya-Garzón, MD | 1 |
Martín Higueras, C | 1 |
Peñalver, P | 1 |
Romera, M | 1 |
Fernandes, MX | 1 |
Franco-Montalbán, F | 1 |
Gómez-Vidal, JA | 1 |
Salido, E | 1 |
Díaz-Gavilán, M | 1 |
1 other study available for mesalamine and Hyperoxaluria, Primary
Article | Year |
---|---|
Salicylic Acid Derivatives Inhibit Oxalate Production in Mouse Hepatocytes with Primary Hyperoxaluria Type 1.
Topics: Alcohol Oxidoreductases; Animals; Cells, Cultured; Computer Simulation; Drug Design; Hepatocytes; Hu | 2018 |